Andrew Rawstron

Andrew Rawstron

MD, PhD

Academic history

Andrew Rawstron, MD, PhD, is a Clinical Scientist at the Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Speaking on MRD in CLL

Dr Rawstron’s primary research focus is on predicting suboptimal responses of patients with chronic lymphocytic leukemia (CLL) with tools such as measurable residual disease (MRD).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter